- 2024-08-20 02:09抑制剂Pimasertib|Pimasertib|1236699-92-5|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:09抑制剂Pimasertib|Pimasertib|1236699-92-5|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:09抑制剂Pinostilbene|Pinostilbene|42438-89-1|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 02:09抑制剂Pinostilbene|Pinostilbene|42438-89-1|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:09抑制剂Pim-1/2 kinase inhibitor 1|Pim-1/2 kinase inhibitor 1|6320-51-0|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 02:09抑制剂Pim-1/2 kinase inhibitor 1|Pim-1/2 kinase inhibitor 1|6320-51-0|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:09抑制剂Pim-1/2 kinase inhibitor 1|Pim-1/2 kinase inhibitor 1|6320-51-0|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:09抑制剂Pimasertib|Pimasertib|1236699-92-5|Adamas life|≥98%（以实测数值为准）|BR|100mg
- 2024-08-20 02:09抑制剂Pilaralisib analogue|Pilaralisib analogue|956958-53-5|Adamas life|≥98%（以实测数值为准）|BR|100mg
- 2024-08-20 02:09抑制剂Pilaralisib analogue|Pilaralisib analogue|956958-53-5|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:09抑制剂Pilaralisib analogue|Pilaralisib analogue|956958-53-5|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:09抑制剂PIK-75 hydrochloride|PIK-75 hydrochloride|372196-77-5|Adamas life|≥98%（以实测数值为准）|BR|500mg
- 2024-08-20 02:09抑制剂PIK-93|PIK-93|593960-11-3|Adamas life|≥98%（以实测数值为准）|BR|100mg
- 2024-08-20 02:09抑制剂PIK-93|PIK-93|593960-11-3|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:09抑制剂PIK-93|PIK-93|593960-11-3|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:09抑制剂Pifithrin-α氢溴酸盐|Pifithrin-α hydrobromide|63208-82-2|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:09抑制剂Pifithrin-α氢溴酸盐|Pifithrin-α hydrobromide|63208-82-2|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:09抑制剂PIK-75 hydrochloride|PIK-75 hydrochloride|372196-77-5|Adamas life|≥98%（以实测数值为准）|BR|100mg
- 2024-08-20 02:09抑制剂PIK-75 hydrochloride|PIK-75 hydrochloride|372196-77-5|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:09抑制剂Pictilisib|Pictilisib|957054-30-7|Adamas life|≥98%（以实测数值为准）|BR|5mg
